Melatonin (Circadin)
Key facts
| Invented name |
Circadin
|
| Active substance |
melatonin
|
| Therapeutic area |
Neurology
|
| Decision number |
P/49/2009
|
| PIP number |
Melatonin (Circadin)
|
| Pharmaceutical form(s) |
Prolonged-release tablet
|
| Condition(s) / indication(s) |
Primary insomnia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
RAD Neurim Pharmaceuticals EEC Ltd
E-mail: talin@neurim.com |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|